|
|
|
|
|
|
|
||
The Journal of General Physiology, Vol 106, 745-779, Copyright © 1995 by The Rockefeller University Press
ARTICLES |
TE DeCoursey
Department of Molecular Biophysics and Physiology, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois 60612, USA.
The mechanism by which the phenylalkylamines, verapamil and D600, and related compounds, block inactivating delayed rectifier K+ currents in rat alveolar epithelial cells, was investigated using whole-cell tight- seal recording. Block by phenylalkylamines added to the bath resembles state-dependent block of squid K+ channels by internally applied quarternary ammonium ions (Armstrong, C.M. 1971. Journal of General Physiology. 58:413-437): open channels are blocked preferentially, increased [K+]o accelerates recovery from block, and recovery occurs mainly through the open state. Slow recovery from block is attributed to the existence of a blocked-inactivated state, because recovery was faster in three situations where recovery from inactivation is faster: (a) at high [K+]o, (b) at more negative potentials, and (c) in cells with type l K+ channels, which recover rapidly from inactivation. The block rate was used as a bioassay to reveal the effective concentration of drug at the block site. When external pH, pHo, was varied, block was much faster at pHo 10 than pHo 7.4, and very slow at pHo 4.5. The block rate was directly proportional to the concentration of neutral drug in the bath, suggesting that externally applied drug must enter the membrane in neutral form to reach the block site. High internal pH (pHi 10) reduced the apparent potency of externally applied phenylalkylamines, suggesting that the cationic form of these drugs blocks K+ channels at an internal site. The permanently charged analogue D890 blocked more potently when added to the pipette than to the bath. However, lowering pHi to 5.5 did not enhance block by external drug, and tertiary phenylalkylamines added to the pipette solution blocked weakly. This result can be explained if drug diffuses out of the cell faster than it is delivered from the pipette, the block site is reached preferentially via hydrophobic pathways, or both. Together, the data indicate the neutral membrane-bound drug blocks K+ channels more potently than intracellular cationic drug. Neutral drug has rapid access to the receptor, where block is stabilized by protonation of the drug from the internal solution. In summary, externally applied phenylalkylamines block open or inactivated K+ channels by partitioning into the cell membrane in neutral form and are stabilized at the block site by protonation.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Husch, S. Hess, and P. Kloppenburg Functional Parameters of Voltage-Activated Ca2+ Currents From Olfactory Interneurons in the Antennal Lobe of Periplaneta americana J Neurophysiol, January 1, 2008; 99(1): 320 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Freeze, M. M. McNulty, and D. A. Hanck State-Dependent Verapamil Block of the Cloned Human Cav3.1 T-Type Ca2+ Channel Mol. Pharmacol., August 1, 2006; 70(2): 718 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dreker and S. Grissmer Investigation of the Phenylalkylamine Binding Site in hKv1.3 (H399T), a Mutant with a Reduced C-Type Inactivated State Mol. Pharmacol., October 1, 2005; 68(4): 966 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ballo, D. Bernabo, and S. A. Faraguti Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia Eur. Heart J., August 1, 2004; 25(15): 1310 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Srinivas and D. C. Spray Closure of Gap Junction Channels by Arylaminobenzoates Mol. Pharmacol., June 1, 2003; 63(6): 1389 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Decoursey Voltage-Gated Proton Channels and Other Proton Transfer Pathways Physiol Rev, April 1, 2003; 83(2): 475 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Rybalchenko, N. Prevarskaya, F. Van Coppenolle, G. Legrand, L. Lemonnier, X. Le Bourhis, and R. Skryma Verapamil Inhibits Proliferation of LNCaP Human Prostate Cancer Cells Influencing K+ Channel Gating Mol. Pharmacol., June 1, 2001; 59(6): 1376 - 1387. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. C. Hogg, C. Trequattrini, L. Catacuzzeno, A. Petris, F. Franciolini, and D. J. Adams Mechanisms of Verapamil Inhibition of Action Potential Firing in Rat Intracardiac Ganglion Neurons J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1502 - 1508. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Zhang, Z. Zhou, Q. Gong, J. C. Makielski, and C. T. January Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels Circ. Res., May 14, 1999; 84(9): 989 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chouabe, M.-D. Drici, G. Romey, J. Barhanin, and M. Lazdunski HERG and KvLQT1/IsK, the Cardiac K+ Channels Involved in Long QT Syndromes, Are Targets for Calcium Channel Blockers Mol. Pharmacol., October 1, 1998; 54(4): 695 - 703. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. H. Hockerman, B. D. Johnson, M. R. Abbott, T. Scheuer, and W. A. Catterall Molecular Determinants of High Affinity Phenylalkylamine Block of L-type Calcium Channels in Transmembrane Segment IIIS6 and the Pore Region of the alpha 1 Subunit J. Biol. Chem., July 25, 1997; 272(30): 18759 - 18765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, J. W. Anderson, and D. Fedida J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1247 - 1256. [Abstract] [Full Text]
|
|
|
|
